Thus, our data support the general notion that 2D parameters of TCR–peptide-major

histocompatibility complex–CD8 interactions determine T-cell responsiveness and suggest a potential 2D-based strategy to screen TCRs for tumor immunotherapy. The interaction between the T-cell receptor (TCR) and peptide-major histocompatibility complex (pMHC) not only defines T-cell specificity and sensitivity but also underpins T-cell development, activation, proliferation, and differentiation [1]. One of the long-lasting interests in immunology is to understand how T-cell functions are related to kinetic properties of the TCR–co-receptor–pMHC interaction. Despite extensive studies on measuring and correlating TCR–pMHC binding kinetics with T-cell activation [2-4], no clear answer has yet been reached [2]. The majority of kinetic studies employ surface plasmon resonance (SPR) technology. SPR measures the intrinsic properties of molecular interaction between C646 ic50 soluble TCRs and pMHCs [5-7]. For naturally occurring TCRs, their interactions with pMHCs are generally of low affinity, with dissociation constants (KD) in the range of 1–100 μM [4]. To reconcile the low affinities with the remarkable sensitivity of T cells to antigens, various models have been proposed, e.g. co-receptors [3, 8], TCR oligomerization [9, 10], and co-agonism [11] models. A large

array of SPR data on various TCR systems and their respective ligands points to the duration of TCR–pMHC engagement (the half-life, or its reciprocal, the off-rate) as Selleckchem Natural Product Library the best correlator with T-cell functional outcomes [2, 12, 13]. However, many outliers exist [14, 15], especially for antagonist ligands [6, 16]. TCR affinity has also been shown to correlate with the strength of T-cell responses [3, 8, 17-19]. In some cases, however, TCR affinity above certain range may lead to plateaued [17, 19] or even attenuated [20-22] T-cell responses. It is often difficult to determine whether the off-rate Idelalisib in vivo or the affinity better predicts T-cell function, because the two parameters are related [4]. A recent study [23] suggested they may predict different aspects

of T-cell activation. Using multimeric binding to overcome the low monomeric TCR–pMHC affinity allows direct staining of the TCR on the T-cell surface with fluorescent pMHC tetramers [5, 8, 24], which also accounts for the co-receptor contribution not considered in most SPR measurements. However, it is difficult to derive intrinsic kinetic parameters from tetramer staining data [25]. Furthermore, pMHC tetramer usually fails to detect weak TCR–pMHC interactions, especially for MHC class II-restricted TCR systems [26]. Both SPR and tetramer staining require one interacting species in the soluble form and thus are termed three-dimensional (3D) measurements [27]. One major caveat of 3D measurements by SPR is that soluble TCR fails to account for possible regulations by the complex T-cell membrane environment.